Loading Events

« All Events

2018 Annual Texas Drug Discovery Symposium

April 12 @ 8:00 am - April 13 @ 5:00 pm

| Free


The Center for Innovative Drug Discovery, a partnership between UT Health SA and UTSA, will hold its 3rd annual Drug Discovery Symposium on April 12-13 at the Greehey Children’s Cancer Research Institute on the north campus of UT Health at San Antonio.

Symposium Agenda:

  • Presentations by national speakers from academic and industry and local researchers engaged in drug discovery and drug development
  • Topics include target discovery and validation, non-druggable targets, novel technologies
  • Drug discovery tools and technologies available in San Antonio
  • Poster and networking sessions

Plenary Keynote Presentation:


Lawrence Goldstein, PhD
Distinguished Professor, Depts. of Cellular and Molecular Medicine and Neurosciences
Director, UC San Diego Stem Cell Program
Scientific Director, Sanford Consortium for Regenerative Medicine
Director, Sanford Stem Cell Clinical Center, UCSD School of Medicine


Session One:  Novel Technologies and Target Approaches  

Jenny Hsieh, PhD, UTSA
Marty Matzuk, MD, PhD, Baylor College of Medicine, DNA encoded libraries

Session Two:  Target Identification & Overcoming Challenging Drug Targets
Kevin Dalby
, PhD, UT Austin, Discovery of a Novel ERK Inhibitor with Activity in BRAF Mutant Melanoma Models
Gorfe Alemayehu
, PhD, University of Texas Medical School, Houston
Karen Vasquez, PhD, UT Austin

Session ThreeScreening and Target Discovery at UT Health San Antonio/UTSA
Rong Li, PhD, UT Health San Antonio
Paul Hasty, PhD, UT Health San Antonio
Stan McHardy, PhD, UTSA

Session Four: Neurological Disease
Jotham Coe
, PhD, Pfizer
Ivy Carroll, PhD, RTI International
Adron Harris, PhD, UT Austin, Transcriptomic and Bioinformatic Approaches for Pharmacotherapy of Alcohol Use Disorders

Session Five: Oncology and Immuno-Oncology
Tyler Curiel
, MD, UT Health San Antonio
Jim Rizzi, PhD, Peleton, HIF2alpha inhibitors
Brian Blagg, PhD, Notre Dame University

Session Six: Cardiovascular and Metabolic Diseases
Stefano Tiziani,
PhD, UT Austin
Harshini Neelakantan, PhD, UT Medical Branch

Closing Remarks:
Bruce Nicholson, PhD
Director, Center for Innovative Drug Discovery
Chairman, Department of Biochemistry and Structural Biology
UT Health San Antonio

To register: https://utsaresearch.wufoo.com/forms/2018-annual-texas-drug-discovery-symposium

>> Download Agenda
>> Download Symposium Flyer
>> Download Local Accommodations
>> View UT Health SA Greehey campus (Map)

Local Accommodations:

  1. Hyatt Place San Antonio Northwest/Medical Center (Rooms blocked for CIDD Conference.)  **Note: has shuttle service to the Symposium at Greehey Children’s Cancer Research Institute
  2. Drury Inn & Suites Northwest Medical Center
  3. Omni San Antonio Hotel at the Colonnade
  4. Homewood Suites Northwest San Antonio Hotel
  5. Embassy Suites – San Antonio Texas Hotel on NW I-10
  6. La Quinta San Antonio Medical Center
  7. Courtyard Mariott


Contact Symposium Co-Chairs:
Matt Hart, Ph.D., Director, Center for Innovative Drug Discovery High Throughput Screening Core Facility, UT Health SA.
Stanton F. McHardy, Ph.D., Co-Director, Center for Innovative Drug Discovery, Director, Max and Minnie Tomerlin Voelcker Medicinal Chemistry Core Facility, UTSA


April 12 @ 8:00 am
April 13 @ 5:00 pm


The Center For Innovative Drug Discovery


Greehey Children’s Cancer Research Institute
8403 Floyd Curl Dr.
San Antonio, TX 78229 United States
+ Google Map